Thalidomide-NH-C10-COOH is primarily utilized in the field of medicinal chemistry for its potential therapeutic applications. It is often studied for its anti-inflammatory and immunomodulatory properties, making it a candidate for treating autoimmune diseases and certain types of cancer. The compound is also explored for its ability to inhibit angiogenesis, which is crucial in preventing the growth of tumors. Additionally, its modified structure allows for enhanced targeting and binding to specific biological molecules, improving its efficacy in drug delivery systems. Researchers are investigating its use in combination therapies to enhance the overall treatment outcomes for various diseases.